Product Program year 2025 Source: CMS Open Payments

Spotlight

Device Sterilization

PDI 10705034207742

Open in the dashboard

General payments

$445,200

379 payments

Research payments

$802,626

4 payments

Through program year 2025, $445,200 in general payments and $802,626 in research payments were reported against Spotlight (Sterilization).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $330,562 178
2024 General $5,555 52
2023 General $5,459 40
2022 General $87,443 73
2022 Research $5,717 1
2021 General $16,181 36
2021 Research $796,909 3

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $347,742 113 payments
  2. DePuy Synthes Products, Inc. $87,935 54 payments
  3. DePuy Synthes Sales Inc. $6,655 132 payments
  4. Johnson & Johnson Health Care Systems Inc. $1,080 17 payments
  5. Johnson & Johnson Vision Care, Inc. $795 15 payments
  6. Janssen Biotech, Inc. $443 29 payments
  7. Abiomed $288 4 payments
  8. Janssen Pharmaceuticals, Inc $179 7 payments
  9. Actelion Pharmaceuticals US, Inc. $40 5 payments
  10. Mentor Worldwide LLC $17 1 payment
Top recipients General payments · program year 2025
  1. Osama Zaidat Vascular Neurology · Toledo, OH $28,000 8% · 5 payments
  2. David Liebeskind Neurology · Los Angeles, CA $27,950 8% · 7 payments
  3. Christopher Kellner Neurological Surgery · New York, NY $16,500 5% · 5 payments
  4. Charles Matouk Neurological Surgery · New Haven, CT $16,060 5% · 2 payments
  5. Edgar Samaniego Vascular & Interventional Radiology · Iowa City, IA $15,805 5% · 4 payments

The top 5 of 81 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurological Surgery $160,981 49% · 21 practitioners
  2. Vascular Neurology Psychiatry & Neurology $61,950 19% · 5 practitioners
  3. Vascular & Interventional Radiology Radiology $36,043 11% · 5 practitioners
  4. Neurology Psychiatry & Neurology $27,950 8% · 1 practitioner
  5. Neuroradiology Radiology $14,150 4% · 3 practitioners

The top 5 of 34 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Connecticut $42,620 13% · 4 recipients
  2. California $42,100 13% · 3 recipients
  3. Ohio $40,930 12% · 3 recipients
  4. Texas $35,371 11% · 13 recipients
  5. Illinois $31,400 9% · 3 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

379 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record